Company at a Glance

InSightec Ltd. is a privately held company owned by Elbit Imaging, General Electric, MediTech Advisors, LLC and employees. It was founded in 1999 to develop the breakthrough MR guided Focused Ultrasound technology and transform it into the next generation operating room. Headquartered near Haifa, Israel, the company has over 160 employees and has invested more than $150 million in research, development, and clinical investigations. Its U.S. headquarters are located in Dallas, Texas.

Technology & Product(s)

InSightec developed the ExAblate® system which integrates Magnetic Resonance Imaging (MRI) with focused ultrasound energy – as a new treatment modality that can replace invasive procedures and provide therapeutic alternatives to various applications. FDA approved to treat uterine fibroids and CE approved to treat bone metastases, the company is conducting intensive research in various fields of medicine aiming to shift the paradigm of surgical treatments, by providing a non-invasive alternative to invasive and minimally invasive surgical procedures. InSightec is conducting research for pain palliation of bone metastases, breast and cancer research. The major benefits are:

• No hospitalization and no general anesthesia
• Quick return to normal activities
• Continous and real time monitoring of treatment by physician

Goal

Objectives: Seeking research partners, and business partners that can distribute such device.
Target businesses: Research institutes and University hospitals in oncology applications using MR guided focused ultrasound technology. Also for dealers/distributors for these fields.
Target Countries: Scandanavia, Spain, Germany, France, Turkey.